Stay updated on Tabelecleucel & Pembrolizumab in EBV+ NPC Clinical Trial

Sign up to get notified when there's something new on the Tabelecleucel & Pembrolizumab in EBV+ NPC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tabelecleucel & Pembrolizumab in EBV+ NPC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision: v3.6.6 was added and Revision: v3.6.5 was removed, indicating the page's version tag has been updated.
    Difference
    0.0%
    Check dated 2026-08-31T17:14:09.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5. No changes to the study content or visible page functionality are evident in the provided screenshots and text.
    Difference
    0.0%
    Check dated 2026-08-10T12:46:53.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.4, replacing the previous Revision: v3.6.3. This reflects a minor update to the page version without altering content.
    Difference
    0.0%
    Check dated 2026-07-27T05:42:49.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.3, replacing Revision: v3.6.2, indicating a small update to the page's revision history.
    Difference
    0.0%
    Check dated 2026-07-05T05:26:37.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    A new site revision entry, v3.6.2, was added to the changelog while the previous entry, v3.6.0, was removed, indicating a software/version update rather than a modification to the study details.
    Difference
    0.0%
    Check dated 2026-06-28T02:06:18.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    The page now includes a recruitment status update 'No longer looking for participants.' It adds new guidance sections 'How to Read a Study Record,' 'Common Questions,' and 'How to Join a Study,' and the revision note updates from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-13T17:05:00.000Z thumbnail image

Stay in the know with updates to Tabelecleucel & Pembrolizumab in EBV+ NPC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tabelecleucel & Pembrolizumab in EBV+ NPC Clinical Trial page.